Ratings Generali

Equities

G

IT0000062072

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-04-18 am EDT			5-day change	1st Jan Change
22.53 ^EUR	0.00%		-0.53%	+17.93%

Apr. 18	Generali reorganises business structure ahead of new strategic plan	RE
Apr. 18	Assicurazioni Generali approves new organizational structure	AN

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

Its low valuation, with P/E ratio at 9.33 and 8.64 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
GENERALI	+17.93%	37.11B	B
AXA	+14.68%	78.32B	B-
METLIFE, INC.	+5.78%	49.83B	B+
AFLAC INCORPORATED	-1.84%	46.18B	B
MANULIFE FINANCIAL CORPORATION	+7.86%	41.02B	B+
PRUDENTIAL FINANCIAL, INC.	+4.83%	38.58B	B+
SUN LIFE FINANCIAL INC.	+1.57%	29.18B	B
GREAT-WEST LIFECO INC.	-8.12%	27.08B	B-
PRUDENTIAL PLC	-18.53%	23.61B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+5.90%	21.64B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes